Hedgehog signaling in lung growth and injury

肺部生长和损伤中的刺猬信号传导

基本信息

  • 批准号:
    8106249
  • 负责人:
  • 金额:
    $ 21.13万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2010
  • 资助国家:
    美国
  • 起止时间:
    2010-07-06 至 2014-06-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): During development, the lung mesenchyme gives rise to non-epithelial structures, while in the mature lung the mesenchyme responds to perturbations to maintain homeostasis. The function, or malfunction, of mesenchymal cells (e.g., fibroblasts, myofibroblasts and smooth muscle cells) is intimately involved with numerous lung diseases, including emphysema, asthma, fibrosis, pulmonary hypertension, cancer and bronchopulmonary dysplasia. There are significant gaps in our knowledge of how resident mesenchymal cells function over time in the lung. Major challenges include the need for additional markers that delineate functionally distinct subtypes of mesenchymal cells, the precise identification of mesenchymal cells that function as resident progenitor or stem cells, and the identification of new signaling pathways or other molecules in mesenchymal cells that can be therapeutically targeted. The broad goal of our work is to identify novel markers of fibroblast subsets, in particular stem/progenitor cells that might be used to identify and therapeutically target these cells in disease states. Sonic hedgehog (Shh) is a signaling molecule involved in mesenchyme proliferation and differentiation during lung development. In lung, Shh is produced by epithelium and induces critical responses in mesenchyme required for branching morphogenesis. While Shh production largely ceases by birth, we find there remains a population of mesenchymal cells in adult lung responding to Shh or a similar Hedgehog (Hh) ligand. These cells are identifiable in Gli1-lacZ reporter mice (the Gli1 gene is both a component of the Hh signaling pathway and a transcriptional target of Hh signaling). The Hh-responding cells have a distinctive location in the adventitia of airways and pulmonary vessels, and in the visceral pleura. By colocalization studies we find that the cells are largely col1+SMA- fibroblasts. Based on our data and recent results on mesenchymal stem/progenitor cells from other groups, we hypothesize that the Gli1-lacZ+ cells are an important population of mesenchymal cells with progenitor/stem cell capability. To test this hypothesis we propose two broad aims: (1) to genetically fate-map the Hh-responding cells under various conditions to determine their ability to expand and contribute to different cell lineages in the lung, and (2) to develop techniques to isolate and culture these cells, and characterize their behavior in vitro. The project will be accomplished by careful analysis of various Hh-reporter mouse strains and cells derived from these mice, and should have broad implications for lung biology and disease. PUBLIC HEALTH RELEVANCE: Lung mesenchymal cells are responsible for synthesis of collagen and other structural proteins, the contractile activity of vessels and airways, repair processes after injury, and maladaptive scarring. Although mesenchymal cells are thought to exist in multiple subtypes that differ in their functions, including their capacity for differentiation, renewal and stem cell behavior, and these functions are critical in diseases such as asthma, pulmonary hypertension and lung fibrosis, our understanding of these subtypes remains inadequate, in part because of a lack of definitive markers by which to identify them. We found that a distinct subset of lung mesenchymal cells is identifiable by activation of the Hedgehog signaling pathway (a pathway that has been most studied in the context of embryonic development), and hypothesize that these cells have important proliferative and progenitor functions in the adult that are relevant to many disease states and that could be targeted for therapeutic benefit; in this application for an R21 award we propose to develop procedures and perform experiments to isolate and characterize these cells in vitro and in vivo.
描述(由申请人提供):在发育过程中,肺间充质产生非上皮结构,而在成熟肺中,间充质对扰动作出反应以维持稳态。间充质细胞的功能或功能障碍(例如,成纤维细胞、肌成纤维细胞和平滑肌细胞)与许多肺部疾病密切相关,包括肺气肿、哮喘、纤维化、肺动脉高压、癌症和支气管肺发育不良。 在我们的知识如何居民间充质细胞功能随着时间的推移在肺部有显着的差距。主要的挑战包括需要额外的标记物来描绘功能上不同的间充质细胞亚型,精确鉴定作为常驻祖细胞或干细胞的间充质细胞,以及鉴定可以治疗靶向的间充质细胞中的新信号传导途径或其他分子。我们工作的广泛目标是鉴定成纤维细胞亚群的新标志物,特别是干/祖细胞,其可用于在疾病状态下鉴定和治疗靶向这些细胞。Sonic hedgehog(Shh)是一种参与肺发育过程中间充质增殖和分化的信号分子。在肺中,Shh由上皮细胞产生,并诱导分支形态发生所需的间充质中的关键反应。虽然Shh的产生在出生时基本上停止,但我们发现在成人肺中仍然存在对Shh或类似的Hedgehog(Hh)配体做出反应的间充质细胞群。这些细胞在Gli 1-lacZ报告小鼠中是可识别的(Gli 1基因既是Hh信号传导途径的组分,也是Hh信号传导的转录靶点)。Hh反应细胞在气道和肺血管的外膜以及脏层胸膜中具有独特的位置。通过共定位研究,我们发现细胞主要是col 1 +SMA-成纤维细胞。基于我们的数据和最近的结果间充质干细胞/祖细胞从其他群体,我们假设Gli 1-lacZ+细胞是一个重要的群体间充质细胞与祖细胞/干细胞的能力。为了验证这一假设,我们提出了两个广泛的目标:(1)在各种条件下对Hh反应细胞进行基因命运图谱,以确定它们在肺中扩增和贡献不同细胞谱系的能力,以及(2)开发分离和培养这些细胞的技术,并表征它们的体外行为。该项目将通过仔细分析各种Hh报告小鼠品系和来自这些小鼠的细胞来完成,并且应该对肺生物学和疾病具有广泛的影响。 公共卫生关系:肺间充质细胞负责胶原蛋白和其他结构蛋白的合成、血管和气道的收缩活动、损伤后的修复过程以及适应不良的瘢痕形成。尽管间充质细胞被认为存在于多种功能不同的亚型中,包括分化,更新和干细胞行为的能力,并且这些功能在哮喘,肺动脉高压和肺纤维化等疾病中至关重要,但我们对这些亚型的理解仍然不足,部分原因是缺乏确定的标记物来识别它们。我们发现,肺间充质细胞的一个独特的子集是可识别的激活刺猬信号通路,(在胚胎发育背景下研究最多的途径),并假设这些细胞在成人中具有重要的增殖和祖细胞功能,其与许多疾病状态相关,并且可以靶向治疗益处;在R21奖申请中,我们提出开发程序并进行实验以在体外和体内分离和表征这些细胞。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

John S Munger其他文献

John S Munger的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('John S Munger', 18)}}的其他基金

Hedgehog signaling in lung growth and injury
肺部生长和损伤中的刺猬信号传导
  • 批准号:
    8764614
  • 财政年份:
    2013
  • 资助金额:
    $ 21.13万
  • 项目类别:
Hedgehog signaling in lung growth and injury
肺部生长和损伤中的刺猬信号传导
  • 批准号:
    7978070
  • 财政年份:
    2010
  • 资助金额:
    $ 21.13万
  • 项目类别:
avb6-mediated TGFb activation in radiation lung fibrosis
avb6介导的放射性肺纤维化中的TGFb激活
  • 批准号:
    7116402
  • 财政年份:
    2004
  • 资助金额:
    $ 21.13万
  • 项目类别:
avb6-mediated TGFb activation in radiation lung fibrosis
avb6介导的放射性肺纤维化中的TGFb激活
  • 批准号:
    7258893
  • 财政年份:
    2004
  • 资助金额:
    $ 21.13万
  • 项目类别:
avb6-mediated TGFb activation in radiation lung fibrosis
avb6介导的放射性肺纤维化中的TGFb激活
  • 批准号:
    6813434
  • 财政年份:
    2004
  • 资助金额:
    $ 21.13万
  • 项目类别:
avb6-mediated TGFb activation in radiation lung fibrosis
avb6介导的放射性肺纤维化中的TGFb激活
  • 批准号:
    6917903
  • 财政年份:
    2004
  • 资助金额:
    $ 21.13万
  • 项目类别:
ACTIVATION OF LATENT TGFB BY THE INTEGRIN ALPHA VB6
整合素 ALPHA VB6 激活潜在 TGFB
  • 批准号:
    6499025
  • 财政年份:
    2000
  • 资助金额:
    $ 21.13万
  • 项目类别:
ACTIVATION OF LATENT TGFB BY THE INTEGRIN ALPHA VB6
整合素 ALPHA VB6 激活潜在 TGFB
  • 批准号:
    6351591
  • 财政年份:
    2000
  • 资助金额:
    $ 21.13万
  • 项目类别:
Activation of latent TGF-beta by integrins
整合素激活潜在的 TGF-β
  • 批准号:
    7116401
  • 财政年份:
    2000
  • 资助金额:
    $ 21.13万
  • 项目类别:
Activation of latent TGF-beta by integrins
整合素激活潜在的 TGF-β
  • 批准号:
    6921339
  • 财政年份:
    2000
  • 资助金额:
    $ 21.13万
  • 项目类别:

相似海外基金

University of Aberdeen and Vertebrate Antibodies Limited KTP 23_24 R1
阿伯丁大学和脊椎动物抗体有限公司 KTP 23_24 R1
  • 批准号:
    10073243
  • 财政年份:
    2024
  • 资助金额:
    $ 21.13万
  • 项目类别:
    Knowledge Transfer Partnership
Role of Natural Antibodies and B1 cells in Fibroproliferative Lung Disease
天然抗体和 B1 细胞在纤维增生性肺病中的作用
  • 批准号:
    10752129
  • 财政年份:
    2024
  • 资助金额:
    $ 21.13万
  • 项目类别:
CAREER: Next-generation protease inhibitor discovery with chemically diversified antibodies
职业:利用化学多样化的抗体发现下一代蛋白酶抑制剂
  • 批准号:
    2339201
  • 财政年份:
    2024
  • 资助金额:
    $ 21.13万
  • 项目类别:
    Continuing Grant
Isolation and characterisation of monoclonal antibodies for the treatment or prevention of antibiotic resistant Acinetobacter baumannii infections
用于治疗或预防抗生素耐药鲍曼不动杆菌感染的单克隆抗体的分离和表征
  • 批准号:
    MR/Y008693/1
  • 财政年份:
    2024
  • 资助金额:
    $ 21.13万
  • 项目类别:
    Research Grant
Developing first-in-class aggregation-specific antibodies for a severe genetic neurological disease
开发针对严重遗传神经系统疾病的一流聚集特异性抗体
  • 批准号:
    10076445
  • 财政年份:
    2023
  • 资助金额:
    $ 21.13万
  • 项目类别:
    Grant for R&D
Discovery of novel nodal antibodies in the central nervous system demyelinating diseases and elucidation of the mechanisms through an optic nerve demyelination model
发现中枢神经系统脱髓鞘疾病中的新型节点抗体并通过视神经脱髓鞘模型阐明其机制
  • 批准号:
    23K14783
  • 财政年份:
    2023
  • 资助金额:
    $ 21.13万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Elucidation of the mechanisms controlling the physicochemical properties and functions of supercharged antibodies and development of their applications
阐明控制超电荷抗体的理化性质和功能的机制及其应用开发
  • 批准号:
    23KJ0394
  • 财政年份:
    2023
  • 资助金额:
    $ 21.13万
  • 项目类别:
    Grant-in-Aid for JSPS Fellows
Role of antibodies in hepatitis E virus infection
抗体在戊型肝炎病毒感染中的作用
  • 批准号:
    10639161
  • 财政年份:
    2023
  • 资助金额:
    $ 21.13万
  • 项目类别:
Defining the protective or pathologic role of antibodies in Post-Ebola Syndrome
定义抗体在埃博拉后综合症中的保护或病理作用
  • 批准号:
    10752441
  • 财政年份:
    2023
  • 资助金额:
    $ 21.13万
  • 项目类别:
Human CMV monoclonal antibodies as therapeutics to inhibit virus infection and dissemination
人 CMV 单克隆抗体作为抑制病毒感染和传播的治疗药物
  • 批准号:
    10867639
  • 财政年份:
    2023
  • 资助金额:
    $ 21.13万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了